Similar Articles
Macular Degeneration and Treatment
Mine Ün, Sedef Öztürk
DOI: 10.5606/jebms.2020.75600
Issue: 2020, Volume 1 - Issue 1
1065
1083
Migraine and Calcitonin Gene-Related Peptide Receptor Antagonist Treatment
Yasemin Akbaş
DOI: 10.5606/jebms.2020.75617
Issue: 2020, Volume 1 - Issue 2
961
952
Familial Autism Genes
Ezgi Seda Yayla
DOI: 10.5606/jebms.2020.75621
Issue: 2020, Volume 1 - Issue 3
1077
1027
What Does CRISPR Technology Provide to Cancer Treatments?
Güner Yaman, Nilsu Çini, İlknur Altuntaş, Oytun Erbaş
DOI: 10.5606/jebms.2021.75637
Issue: 2021, Volume 2 - Issue 1
1254
767
Multiple Myeloma Treatment
Edanur Tekin, Özge Çağlar, Elif Özyılmaz, Oytun Erbaş
DOI: 10.5606/jebms.2021.75658
Issue: 2021, Volume 2 - Issue 2
636
572
Metformin as Cancer Preventative and Therapeutic Agent
İlayda Üzümcü, Burak Akverdi, Elif Ünaldı, Oytun Erbaş
DOI: 10.5606/jebms.2022.1006
Issue: 2022, Volume 3 - Issue 1
890
534
Depression and Cardiovascular Disease: A Mutual Relationship
Bahar Işık,Oytun Erbaş
DOI: 10.5606/jebms.2023.1041
Issue: 2023, Volume 4 - Issue 1
464
520
Emerging Immunotherapeutic Approaches for Managing Metastasis
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2023.1050
Issue: 2023, Volume 4 - Issue 2
490
449
Revolutionizing Health Technologies: The Transformative Power of Stem Cells
Tutku Özaydın, Kerem Can Tunç, Oytun Erbaş
DOI: 10.5606/jebms.2024.1071
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
279
312
Stem Cell Applications: A Promising Future for Autoimmune Diseases?
Öznur Safgöl, Oytun Erbaş
DOI: 10.5606/jebms.2024.1075
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
282
313
Stem Cells in Surgery
Buse Kaptan, Oytun Erbaş
DOI: 10.5606/jebms.2024.1080
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
282
255
Cancer Stem Cells
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2024.1083
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
366
277